|
|
||||||||
Boston, Mass.
ABSTRACT
The prior administration of an oral cholecystographic compound, Oragrafin, was occasionally associated with a rise in the resin sponge and resin T3 uptake into the thyrotoxic range. The TBI and charcoal T3 ratio were not altered by this dye.
FOOTNOTES
1 From the Endocrine Division, St. Elizabeth's Hospital, and the Department of Medicine, Tufts Medical School; and the Thorndike Memorial Laboratory and the Second and Fourth (Harvard) Medical Services, Boston City Hospital, and the Department of Medicine, Harvard Medical School, Boston, Massachusetts.
2 This study was supported by Grant AM-07917 from the National Institute of Arthritis and Metabolic Diseases and by USPHS Research Grant FR-76 from the Division of Research Facilities and Resources, NIH, Bethesda, Maryland.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |